Abstract: This invention relates to 1-amino naphthyridines prepared by a base-catalyzed condensation while in an aprotic solvent. In this condensation an o-alkyl aryl nitrile may be reacted either with the same or different o-alkyl aryl nitrile or with another nitrile. The 1-amino naphthyridines are useful as antifungal and antibacterial agents.
Abstract: This application is directed to novel sulfonyl urea compounds, their non-toxic pharmaceutically acceptable salts, and to processes for making and using said compound. Exemplary of the sulfonyl ureas of this invention is N-(aralkyl)-N'-(p-benzenesulfonyl)urea.
Type:
Grant
Filed:
March 15, 1976
Date of Patent:
April 5, 1977
Assignee:
Schering Corporation
Inventors:
Lester Zitowitz, Lewis A. Walter, Arnold J. Wohl
Abstract: Micromonospora inyoensis strain 1550F-1G NRRL 5742 is incapable of producing antibiotics unless an aminocyclitol is added to the fermentation medium. When such a compound is added, mutamicins are produced, said mutamicins being analogs of known aminoglycoside antibiotics differing therefrom with respect to the aminocyclitol subunit.
Type:
Grant
Filed:
June 5, 1974
Date of Patent:
March 8, 1977
Assignee:
Schering-Plough Corporation
Inventors:
Marvin J. Weinstein, Peter J. L. Daniels, Gerald H. Wagman, Raymond Testa
Abstract: Aminoglycoside 66-40C, a minor product produced by the fermentation of Micromonospora inyoensis, is separated from said fermentation mixture, and is used as an intermediate in preparing the known antibiotic, sisomicin, as well as 6' -N-alkylsisomicins having antibacterial activity. Claimed are Aminoglycoside 66-40C as well as 6' -N-t-alkylsisomicins having a tertiary carbon bonded to the 6' -nitrogen.
Type:
Grant
Filed:
May 2, 1975
Date of Patent:
February 22, 1977
Assignee:
Schering Corporation
Inventors:
Alan K. Mallams, Richard W. Tkach, David Huw Davies
Abstract: A mutant strain of Micromonospora purpurea herein designated M. purpurea JI-20 elaborates an antibiotic complex comprising gentamicin and at least two novel antibiotic substances namely Antibiotic JI-20A and Antibiotic JI-20B. The so-produced antibiotics have an adverse effect upon the growth of gram-positive and gram-negative bacteria.
Type:
Grant
Filed:
June 9, 1975
Date of Patent:
February 22, 1977
Assignee:
Schering Corporation
Inventors:
Jan Ilavsky, Aris P. Bayan, William Charney, Hans Reimann
Abstract: A novel actinomycete herein designated Micromonospora zionensis elaborates a product having substantial antibacterial activity, said activity being due to sisomicin and the novel antibiotic substance coproduced therewith. The disclosure sets forth methods for producing, isolating and using the antibiotics.
Type:
Grant
Filed:
February 28, 1975
Date of Patent:
January 4, 1977
Assignee:
Schering Corporation
Inventors:
Marvin J. Weinstein, Gerald H. Wagman, Joseph A. Marquez
Abstract: Disclosed herein is an aerosol package and method using this package for dispensing substances in spray form and depositing them on a desired limited surface area in the form of a buttery, liquescent solid. The aerosol packaging contains an anhydrous, oleaginous base containing specified fats or waxes and a propellant miscible therewith.
Type:
Grant
Filed:
September 16, 1971
Date of Patent:
January 4, 1977
Assignee:
Plough, Inc.
Inventors:
Wolffe Harry Feinstone, Fred J. Bandelin
Abstract: An applicator for applying a predetermined metered amount of a cosmetic material characterized by a plurality of axially spaced coating surfaces in which the axial distance between each coating surface is adjustable.
Abstract: A novel actinomycete herein designated Micromonospora rhodorangea elaborates a product having substantial antibacterial activity, said activity being due primarily to a novel antibiotic herein designated Antibiotic G-418. The disclosure sets forth methods for producing, isolating and using said antibiotic.
Type:
Grant
Filed:
October 10, 1975
Date of Patent:
December 14, 1976
Assignee:
Schering Corporation
Inventors:
Marvin J. Weinstein, Gerald H. Wagman, Raymond T. Testa, Joseph A. Marquez
Abstract: This application relates to certain 4'-substituted and to 3',4'-disubstituted anilides, to methods for their preparation and to methods for their use as antiandrogens. These substituted anilides are useful in the treatment of androgen dependent disease states, such as benign prostatic hypertrophy, hirsutism, acne and the like.
Abstract: The present 2-substituted imidazolines possess valuable hypoglycemic activity. The compounds are prepared by the condensation of an appropriately substituted aryl nitrile with a diamine.
Abstract: A novel composition having antibiotic activity is produced by fermentation of the new species of microorganism, Micromonospora grisea. The antibiotic complex is composed of four components, Verdamicin I, sisomicin, Antibiotic G-418, and gentamicin A, of which Verdamicin I is a novel basic antibiotic possessing a broad antibacterial spectrum. The other components have been produced previously.
Type:
Grant
Filed:
February 18, 1975
Date of Patent:
October 26, 1976
Assignee:
Schering Corporation
Inventors:
Marvin J. Weinstein, Gerald H. Wagman, Joseph A. Marquez
Abstract: A mutant strain of Micromonospora purpurea herein designated M. purpurea JI-20 elaborates an antibiotic complex comprising gentamicin and at least two novel antibiotic substances namely Antibiotic JI-20A and Antibiotic JI-20B. The so-produced antibiotics have an adverse effect upon the growth of gram-positive and gram-negative bacteria.
Type:
Grant
Filed:
June 9, 1975
Date of Patent:
October 19, 1976
Assignee:
Schering Corporation
Inventors:
Jan Ilavsky, Aris P. Bayan, William Charney, Hans Reimann
Abstract: This disclosure relates to the preparation of certain gentamine derivatives, to their use as intermediates in the preparation of certain novel pseudotrisaccharides containing a gentamine moiety, and to the use of these pseudotrisaccharides as antibacterial agents.
Abstract: Fermentation of Micromono spora purpurea NRRL 2953 under controlled aerobic conditions produces a plurality of antibiotic substances including gentamicin C.sub.2a which has been heretofore unknown and unrecognized. A method of isolating said antibiotic is described as are the chemical and biological properties of the same.
Abstract: Disclosed are 2-cyanoethyl amino alkyl-3-phenyl indoles of the formula ##SPC1##Wherein n 1, X.sub.2, Y.sub.1 and Y.sub.2 are hydrogen or halogen, at least one of X.sub.1 and X.sub.2 being halogen; n is an integer selected from 1,2 and 3; and the acid addition salts thereof which are useful as antimicrobials.
Abstract: Described is a novel process for the preparation of 12,13-desepoxy-12,13-dehydrorosamicin by reducing rosamicin in a mineral acid solution containing Cr.sup.+.sup.+ cations. Rosamicin is an antibiotic elaborated by Micromonospora rosaria.